Vitiligo: Mechanisms of Pathogenesis and Treatment
- PMID: 32017656
- DOI: 10.1146/annurev-immunol-100919-023531
Vitiligo: Mechanisms of Pathogenesis and Treatment
Abstract
Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes and results in patches of depigmentation that are visible as white spots. Recent research studies have yielded a strong mechanistic understanding of this disease. Autoreactive cytotoxic CD8+ T cells engage melanocytes and promote disease progression through the local production of IFN-γ, and IFN-γ-induced chemokines are then secreted from surrounding keratinocytes to further recruit T cells to the skin through a positive-feedback loop. Both topical and systemic treatments that block IFN-γ signaling can effectively reverse vitiligo in humans; however, disease relapse is common after stopping treatments. Autoreactive resident memory T cells are responsible for relapse, and new treatment strategies focus on eliminating these cells to promote long-lasting benefit. Here, we discuss basic, translational, and clinical research studies that provide insight into the pathogenesis of vitiligo, and how this insight has been utilized to create new targeted treatment strategies.
Keywords: IL-15; JAK inhibition; autoimmunity; immune resident memory; vitiligo.
Similar articles
-
Vitiligo: A focus on pathogenesis and its therapeutic implications.J Dermatol. 2021 Mar;48(3):252-270. doi: 10.1111/1346-8138.15743. Epub 2021 Jan 6. J Dermatol. 2021. PMID: 33404102 Review.
-
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.Front Immunol. 2021 Nov 18;12:790125. doi: 10.3389/fimmu.2021.790125. eCollection 2021. Front Immunol. 2021. PMID: 34868078 Free PMC article. Review.
-
The Role of Memory CD8+ T Cells in Vitiligo.J Immunol. 2019 Jul 1;203(1):11-19. doi: 10.4049/jimmunol.1900027. J Immunol. 2019. PMID: 31209143 Free PMC article. Review.
-
Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.J Invest Dermatol. 2017 Feb;137(2):350-358. doi: 10.1016/j.jid.2016.09.016. Epub 2016 Sep 26. J Invest Dermatol. 2017. PMID: 27686391 Free PMC article.
-
Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics.Autoimmun Rev. 2021 Aug;20(8):102868. doi: 10.1016/j.autrev.2021.102868. Epub 2021 Jun 10. Autoimmun Rev. 2021. PMID: 34118458 Review.
Cited by
-
Causal Associations between Vitamin D Levels and Psoriasis, Atopic Dermatitis, and Vitiligo: A Bidirectional Two-Sample Mendelian Randomization Analysis.Nutrients. 2022 Dec 11;14(24):5284. doi: 10.3390/nu14245284. Nutrients. 2022. PMID: 36558443 Free PMC article.
-
The Function of Autophagy as a Regulator of Melanin Homeostasis.Cells. 2022 Jun 30;11(13):2085. doi: 10.3390/cells11132085. Cells. 2022. PMID: 35805169 Free PMC article. Review.
-
Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence.Ann Med. 2024 Dec;56(1):2326297. doi: 10.1080/07853890.2024.2326297. Epub 2024 Sep 19. Ann Med. 2024. PMID: 39300810 Free PMC article.
-
Identification of TYR, TYRP1, DCT and LARP7 as related biomarkers and immune infiltration characteristics of vitiligo via comprehensive strategies.Bioengineered. 2021 Dec;12(1):2214-2227. doi: 10.1080/21655979.2021.1933743. Bioengineered. 2021. PMID: 34107850 Free PMC article.
-
Fibromyalgia and Skin Disorders: A Systematic Review.J Clin Med. 2024 Jul 27;13(15):4404. doi: 10.3390/jcm13154404. J Clin Med. 2024. PMID: 39124671 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
